nodes	percent_of_prediction	percent_of_DWPC	metapath
Naltrexone—UGT1A1—urine—nephrolithiasis	0.0467	0.443	CbGeAlD
Naltrexone—Stiffness—Hydrochlorothiazide—nephrolithiasis	0.0452	0.0505	CcSEcCtD
Naltrexone—Sexual dysfunction—Hydrochlorothiazide—nephrolithiasis	0.0306	0.0342	CcSEcCtD
Naltrexone—Toothache—Hydrochlorothiazide—nephrolithiasis	0.0282	0.0316	CcSEcCtD
Naltrexone—Gamma-glutamyltransferase increased—Hydrochlorothiazide—nephrolithiasis	0.0209	0.0233	CcSEcCtD
Naltrexone—Musculoskeletal stiffness—Hydrochlorothiazide—nephrolithiasis	0.0191	0.0214	CcSEcCtD
Naltrexone—Gastrooesophageal reflux disease—Hydrochlorothiazide—nephrolithiasis	0.019	0.0213	CcSEcCtD
Naltrexone—Hypercholesterolaemia—Hydrochlorothiazide—nephrolithiasis	0.0182	0.0203	CcSEcCtD
Naltrexone—Sleep disorder—Hydrochlorothiazide—nephrolithiasis	0.0144	0.0161	CcSEcCtD
Naltrexone—Swelling—Hydrochlorothiazide—nephrolithiasis	0.0141	0.0158	CcSEcCtD
Naltrexone—Gastroenteritis—Hydrochlorothiazide—nephrolithiasis	0.0141	0.0157	CcSEcCtD
Naltrexone—Nasal congestion—Hydrochlorothiazide—nephrolithiasis	0.0137	0.0153	CcSEcCtD
Naltrexone—Libido decreased—Hydrochlorothiazide—nephrolithiasis	0.0134	0.015	CcSEcCtD
Naltrexone—Hot flush—Hydrochlorothiazide—nephrolithiasis	0.0133	0.0149	CcSEcCtD
Naltrexone—Increased appetite—Hydrochlorothiazide—nephrolithiasis	0.0133	0.0148	CcSEcCtD
Naltrexone—Menopausal symptoms—Hydrochlorothiazide—nephrolithiasis	0.0132	0.0148	CcSEcCtD
Naltrexone—OPRD1—renal system—nephrolithiasis	0.0132	0.125	CbGeAlD
Naltrexone—Atrial fibrillation—Hydrochlorothiazide—nephrolithiasis	0.0132	0.0147	CcSEcCtD
Naltrexone—Thirst—Hydrochlorothiazide—nephrolithiasis	0.0131	0.0146	CcSEcCtD
Naltrexone—Purpura—Hydrochlorothiazide—nephrolithiasis	0.0129	0.0145	CcSEcCtD
Naltrexone—Arthritis—Hydrochlorothiazide—nephrolithiasis	0.0128	0.0143	CcSEcCtD
Naltrexone—OPRD1—kidney—nephrolithiasis	0.0128	0.121	CbGeAlD
Naltrexone—Pain in extremity—Hydrochlorothiazide—nephrolithiasis	0.0125	0.0139	CcSEcCtD
Naltrexone—Gastrointestinal haemorrhage—Hydrochlorothiazide—nephrolithiasis	0.0125	0.0139	CcSEcCtD
Naltrexone—Disturbance in sexual arousal—Hydrochlorothiazide—nephrolithiasis	0.0124	0.0138	CcSEcCtD
Naltrexone—Migraine—Hydrochlorothiazide—nephrolithiasis	0.0123	0.0137	CcSEcCtD
Naltrexone—Face oedema—Hydrochlorothiazide—nephrolithiasis	0.012	0.0135	CcSEcCtD
Naltrexone—UGT1A1—renal system—nephrolithiasis	0.0114	0.108	CbGeAlD
Naltrexone—Abdominal pain upper—Hydrochlorothiazide—nephrolithiasis	0.0114	0.0127	CcSEcCtD
Naltrexone—Cramp muscle—Hydrochlorothiazide—nephrolithiasis	0.0112	0.0125	CcSEcCtD
Naltrexone—Aspartate aminotransferase increased—Hydrochlorothiazide—nephrolithiasis	0.0112	0.0125	CcSEcCtD
Naltrexone—UGT1A1—kidney—nephrolithiasis	0.0111	0.105	CbGeAlD
Naltrexone—Alanine aminotransferase increased—Hydrochlorothiazide—nephrolithiasis	0.011	0.0123	CcSEcCtD
Naltrexone—Influenza—Hydrochlorothiazide—nephrolithiasis	0.0108	0.012	CcSEcCtD
Naltrexone—Angina pectoris—Hydrochlorothiazide—nephrolithiasis	0.0105	0.0117	CcSEcCtD
Naltrexone—Upper respiratory tract infection—Hydrochlorothiazide—nephrolithiasis	0.01	0.0112	CcSEcCtD
Naltrexone—Weight increased—Hydrochlorothiazide—nephrolithiasis	0.0098	0.011	CcSEcCtD
Naltrexone—Pneumonia—Hydrochlorothiazide—nephrolithiasis	0.00966	0.0108	CcSEcCtD
Naltrexone—Acute coronary syndrome—Hydrochlorothiazide—nephrolithiasis	0.00947	0.0106	CcSEcCtD
Naltrexone—Myocardial infarction—Hydrochlorothiazide—nephrolithiasis	0.00942	0.0105	CcSEcCtD
Naltrexone—Conjunctivitis—Hydrochlorothiazide—nephrolithiasis	0.00934	0.0104	CcSEcCtD
Naltrexone—Urinary tract infection—Hydrochlorothiazide—nephrolithiasis	0.00934	0.0104	CcSEcCtD
Naltrexone—Epistaxis—Hydrochlorothiazide—nephrolithiasis	0.00906	0.0101	CcSEcCtD
Naltrexone—Sinusitis—Hydrochlorothiazide—nephrolithiasis	0.00901	0.0101	CcSEcCtD
Naltrexone—Hepatitis—Hydrochlorothiazide—nephrolithiasis	0.00862	0.00964	CcSEcCtD
Naltrexone—Pharyngitis—Hydrochlorothiazide—nephrolithiasis	0.00856	0.00957	CcSEcCtD
Naltrexone—Tinnitus—Hydrochlorothiazide—nephrolithiasis	0.00804	0.00899	CcSEcCtD
Naltrexone—Alopecia—Hydrochlorothiazide—nephrolithiasis	0.00762	0.00852	CcSEcCtD
Naltrexone—Flatulence—Hydrochlorothiazide—nephrolithiasis	0.0074	0.00827	CcSEcCtD
Naltrexone—Tension—Hydrochlorothiazide—nephrolithiasis	0.00737	0.00823	CcSEcCtD
Naltrexone—Dysgeusia—Hydrochlorothiazide—nephrolithiasis	0.00735	0.00822	CcSEcCtD
Naltrexone—Nervousness—Hydrochlorothiazide—nephrolithiasis	0.00729	0.00815	CcSEcCtD
Naltrexone—Back pain—Hydrochlorothiazide—nephrolithiasis	0.00726	0.00812	CcSEcCtD
Naltrexone—Muscle spasms—Hydrochlorothiazide—nephrolithiasis	0.00722	0.00807	CcSEcCtD
Naltrexone—Vision blurred—Hydrochlorothiazide—nephrolithiasis	0.00707	0.00791	CcSEcCtD
Naltrexone—Tremor—Hydrochlorothiazide—nephrolithiasis	0.00703	0.00786	CcSEcCtD
Naltrexone—Ill-defined disorder—Hydrochlorothiazide—nephrolithiasis	0.00696	0.00779	CcSEcCtD
Naltrexone—Agitation—Hydrochlorothiazide—nephrolithiasis	0.0069	0.00771	CcSEcCtD
Naltrexone—Angioedema—Hydrochlorothiazide—nephrolithiasis	0.00686	0.00767	CcSEcCtD
Naltrexone—Malaise—Hydrochlorothiazide—nephrolithiasis	0.00677	0.00757	CcSEcCtD
Naltrexone—Syncope—Hydrochlorothiazide—nephrolithiasis	0.00673	0.00753	CcSEcCtD
Naltrexone—Palpitations—Hydrochlorothiazide—nephrolithiasis	0.00663	0.00742	CcSEcCtD
Naltrexone—Loss of consciousness—Hydrochlorothiazide—nephrolithiasis	0.0066	0.00738	CcSEcCtD
Naltrexone—Cough—Hydrochlorothiazide—nephrolithiasis	0.00655	0.00732	CcSEcCtD
Naltrexone—Arthralgia—Hydrochlorothiazide—nephrolithiasis	0.00639	0.00714	CcSEcCtD
Naltrexone—Chest pain—Hydrochlorothiazide—nephrolithiasis	0.00639	0.00714	CcSEcCtD
Naltrexone—Myalgia—Hydrochlorothiazide—nephrolithiasis	0.00639	0.00714	CcSEcCtD
Naltrexone—Anxiety—Hydrochlorothiazide—nephrolithiasis	0.00637	0.00712	CcSEcCtD
Naltrexone—Discomfort—Hydrochlorothiazide—nephrolithiasis	0.00631	0.00706	CcSEcCtD
Naltrexone—Dry mouth—Hydrochlorothiazide—nephrolithiasis	0.00625	0.00699	CcSEcCtD
Naltrexone—Confusional state—Hydrochlorothiazide—nephrolithiasis	0.00618	0.00691	CcSEcCtD
Naltrexone—Anaphylactic shock—Hydrochlorothiazide—nephrolithiasis	0.00613	0.00685	CcSEcCtD
Naltrexone—Oedema—Hydrochlorothiazide—nephrolithiasis	0.00613	0.00685	CcSEcCtD
Naltrexone—Shock—Hydrochlorothiazide—nephrolithiasis	0.00603	0.00674	CcSEcCtD
Naltrexone—Tachycardia—Hydrochlorothiazide—nephrolithiasis	0.00598	0.00668	CcSEcCtD
Naltrexone—Hyperhidrosis—Hydrochlorothiazide—nephrolithiasis	0.00592	0.00662	CcSEcCtD
Naltrexone—Anorexia—Hydrochlorothiazide—nephrolithiasis	0.00584	0.00653	CcSEcCtD
Naltrexone—Musculoskeletal discomfort—Hydrochlorothiazide—nephrolithiasis	0.00558	0.00624	CcSEcCtD
Naltrexone—Insomnia—Hydrochlorothiazide—nephrolithiasis	0.00554	0.00619	CcSEcCtD
Naltrexone—Paraesthesia—Hydrochlorothiazide—nephrolithiasis	0.0055	0.00615	CcSEcCtD
Naltrexone—Dyspnoea—Hydrochlorothiazide—nephrolithiasis	0.00546	0.00611	CcSEcCtD
Naltrexone—Somnolence—Hydrochlorothiazide—nephrolithiasis	0.00545	0.00609	CcSEcCtD
Naltrexone—Decreased appetite—Hydrochlorothiazide—nephrolithiasis	0.00533	0.00595	CcSEcCtD
Naltrexone—Fatigue—Hydrochlorothiazide—nephrolithiasis	0.00528	0.0059	CcSEcCtD
Naltrexone—Pain—Hydrochlorothiazide—nephrolithiasis	0.00524	0.00586	CcSEcCtD
Naltrexone—Constipation—Hydrochlorothiazide—nephrolithiasis	0.00524	0.00586	CcSEcCtD
Naltrexone—Feeling abnormal—Hydrochlorothiazide—nephrolithiasis	0.00505	0.00564	CcSEcCtD
Naltrexone—Gastrointestinal pain—Hydrochlorothiazide—nephrolithiasis	0.00501	0.0056	CcSEcCtD
Naltrexone—Urticaria—Hydrochlorothiazide—nephrolithiasis	0.00487	0.00544	CcSEcCtD
Naltrexone—Abdominal pain—Hydrochlorothiazide—nephrolithiasis	0.00484	0.00541	CcSEcCtD
Naltrexone—Body temperature increased—Hydrochlorothiazide—nephrolithiasis	0.00484	0.00541	CcSEcCtD
Naltrexone—Hypersensitivity—Hydrochlorothiazide—nephrolithiasis	0.00451	0.00505	CcSEcCtD
Naltrexone—Asthenia—Hydrochlorothiazide—nephrolithiasis	0.0044	0.00491	CcSEcCtD
Naltrexone—Pruritus—Hydrochlorothiazide—nephrolithiasis	0.00433	0.00485	CcSEcCtD
Naltrexone—Diarrhoea—Hydrochlorothiazide—nephrolithiasis	0.00419	0.00469	CcSEcCtD
Naltrexone—Dizziness—Hydrochlorothiazide—nephrolithiasis	0.00405	0.00453	CcSEcCtD
Naltrexone—Vomiting—Hydrochlorothiazide—nephrolithiasis	0.00389	0.00435	CcSEcCtD
Naltrexone—Rash—Hydrochlorothiazide—nephrolithiasis	0.00386	0.00432	CcSEcCtD
Naltrexone—Dermatitis—Hydrochlorothiazide—nephrolithiasis	0.00386	0.00431	CcSEcCtD
Naltrexone—Headache—Hydrochlorothiazide—nephrolithiasis	0.00384	0.00429	CcSEcCtD
Naltrexone—Nausea—Hydrochlorothiazide—nephrolithiasis	0.00364	0.00407	CcSEcCtD
Naltrexone—ABCB1—nephron tubule—nephrolithiasis	0.00285	0.027	CbGeAlD
Naltrexone—ABCB1—renal system—nephrolithiasis	0.00259	0.0246	CbGeAlD
Naltrexone—ABCB1—kidney—nephrolithiasis	0.00251	0.0238	CbGeAlD
Naltrexone—ABCB1—cortex of kidney—nephrolithiasis	0.00244	0.0231	CbGeAlD
